Clinical Trial Update: A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Zanzalintinib in advanced/metastatic bone sarcomas; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma

Drugs mentioned

• Zanzalintinib (Zanzalintinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bone Sarcomas | Phase 2 | Status: RECRUITING